
Alert: New Earnings Report (2/27/25)-Amphastar Pharmaceuticals Inc (NASDAQ: AMPH).
For its fourth fiscal quarter (ending December 31), Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) has reported a 5% increase in E.P.S. from $0.75 a year ago to $0.79 in the current quarter. E.P.S. were $3.29 for […]